NCT07907406
Comparison Between Efficacy of Gabapentin and Carbamazepine in Neuropathic Pain of Guillain-Barré Syndrome Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Mean neuropathic pain score
Timeframe: Baseline and 7 day after initiation of treatment.
Arms and interventions
Group A-GabapentinExperimental
Patients received gabapentin 300 mg three times daily for seven days after plasma exchange for Guillain-Barré syndrome.
Group B-CarbamazepineActive comparator
Patients received carbamazepine 100 mg three times daily after plasma exchange
Drugs: Gabapentin, Carbamazepine
Sites
1 site in 1 country
- Lahore General Hospital, LahoreLahore, Punjab Province, Pakistan